DK3041576T3 - Fremgangsmåder til at detektere nyresygdom - Google Patents
Fremgangsmåder til at detektere nyresygdom Download PDFInfo
- Publication number
- DK3041576T3 DK3041576T3 DK14842603.4T DK14842603T DK3041576T3 DK 3041576 T3 DK3041576 T3 DK 3041576T3 DK 14842603 T DK14842603 T DK 14842603T DK 3041576 T3 DK3041576 T3 DK 3041576T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- kidney disease
- detecting kidney
- detecting
- disease
- Prior art date
Links
- 208000017169 kidney disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361874011P | 2013-09-05 | 2013-09-05 | |
| PCT/US2014/054278 WO2015035155A1 (en) | 2013-09-05 | 2014-09-05 | Methods for detecting renal disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3041576T3 true DK3041576T3 (da) | 2019-09-09 |
Family
ID=52628954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14842603.4T DK3041576T3 (da) | 2013-09-05 | 2014-09-05 | Fremgangsmåder til at detektere nyresygdom |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11035861B2 (da) |
| EP (3) | EP4295907A3 (da) |
| JP (4) | JP6657096B2 (da) |
| KR (2) | KR102412431B1 (da) |
| CN (1) | CN105705202B (da) |
| AU (2) | AU2014315063B2 (da) |
| CA (2) | CA2923140C (da) |
| CY (1) | CY1123179T1 (da) |
| DK (1) | DK3041576T3 (da) |
| ES (2) | ES2746008T3 (da) |
| HR (1) | HRP20191569T1 (da) |
| HU (1) | HUE045723T2 (da) |
| LT (1) | LT3041576T (da) |
| MX (2) | MX383274B (da) |
| NZ (1) | NZ717554A (da) |
| PL (1) | PL3041576T3 (da) |
| PT (1) | PT3041576T (da) |
| RS (1) | RS59287B1 (da) |
| SI (1) | SI3041576T1 (da) |
| SM (1) | SMT201900526T1 (da) |
| WO (1) | WO2015035155A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE045723T2 (hu) | 2013-09-05 | 2020-01-28 | Idexx Lab Inc | Módszerek vesebetegség kimutatására |
| US10775365B2 (en) | 2015-02-20 | 2020-09-15 | Idexx Laboratories, Inc. | Homogenous immunoassay with compensation for background signal |
| ES3041077T3 (en) * | 2015-04-30 | 2025-11-07 | Idexx Lab Inc | Methods for detecting renal disease |
| US11771113B2 (en) | 2017-05-31 | 2023-10-03 | Mars, Incorporated | Methods of diagnosing and treating chronic kidney disease |
| US11026625B2 (en) | 2017-08-08 | 2021-06-08 | Fresenius Medical Care Holdings, Inc. | Systems and methods for treating and estimating progression of chronic kidney disease |
| AU2018351349B2 (en) * | 2017-10-19 | 2025-08-14 | Idexx Laboratories, Inc. | Detection of symmetrical dimethylarginine |
| WO2020080484A1 (ja) * | 2018-10-17 | 2020-04-23 | 株式会社 資生堂 | 糸球体濾過能力の決定方法 |
| CN109545377B (zh) * | 2018-10-22 | 2021-11-23 | 中南大学湘雅三医院 | 获取肾小球滤过率的模型的建立方法 |
| US10745492B1 (en) * | 2019-04-03 | 2020-08-18 | Ark Diagnostics, Inc. | Antibodies to symmetrically dimethylated arginine analytes and use thereof |
| WO2021046339A1 (en) | 2019-09-05 | 2021-03-11 | The Regents Of The University Of California | Noninvasive method to quantify kidney function and functional decline |
| WO2021132658A1 (ja) * | 2019-12-27 | 2021-07-01 | Kagami株式会社 | 腎機能を推定する方法及びシステム |
| GB202005110D0 (en) * | 2020-04-07 | 2020-05-20 | Royal Veterinary College | Diagnosis of stage b2 dmvd |
| JP7784798B2 (ja) * | 2020-04-17 | 2025-12-12 | 株式会社藤商事 | 遊技機 |
| EP4263383A4 (en) | 2020-12-17 | 2024-10-23 | Nephrosant, Inc. | KITS FOR STABILIZATION OF URINE SAMPLES |
| CN112768073B (zh) * | 2021-01-15 | 2023-04-18 | 中山大学附属第三医院 | 一种肾小球滤过率估计模型的构建方法 |
| JP2023160475A (ja) * | 2022-04-22 | 2023-11-02 | 株式会社三共 | 遊技機 |
| KR102880012B1 (ko) * | 2023-12-22 | 2025-11-10 | 주식회사 페토바이오 | 반려동물의 신부전 치료를 위한 임상 의사결정 지원 시스템 및 임상 의사결정 지원 방법 |
| CN119125582A (zh) * | 2024-09-20 | 2024-12-13 | 武汉虹之彩包装印刷有限公司 | 一种用于肌酐检测的纸基传感器及其制备方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134787A1 (de) | 1981-09-02 | 1983-03-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Creatinin-antikoerper |
| US4818703A (en) | 1985-10-23 | 1989-04-04 | Pizzolante John M | Stabilized alkaline picrate reagent for jaffe creatinine determination |
| EP0356160A3 (en) | 1988-08-24 | 1991-09-11 | The Board Of Trustees Of The Leland Stanford Junior University | Capillary device |
| US5726010A (en) | 1991-07-31 | 1998-03-10 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| US6455288B1 (en) | 1993-04-08 | 2002-09-24 | Dade Behring Marburg Gmbh | Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
| US5804452A (en) * | 1995-04-27 | 1998-09-08 | Quidel Corporation | One step urine creatinine assays |
| WO1998049199A1 (en) | 1997-05-01 | 1998-11-05 | Panorama Research, Inc. | Cardiovascular disease risk assessment |
| US6736957B1 (en) | 1997-10-16 | 2004-05-18 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors and process for using |
| US6358699B1 (en) | 1999-02-05 | 2002-03-19 | Cooke Pharma | Assay for asymmetrical NG, NG dimethyl-l-arginine |
| US6699673B2 (en) | 1999-12-22 | 2004-03-02 | The Research Foundation Of State University Of New York | Protein methylarginine-specific antibodies |
| JP2004502948A (ja) | 2000-07-06 | 2004-01-29 | ファル ダイアグノスティクス | アルギニン化合物の検出のための方法及びキット |
| DE60133558D1 (de) * | 2000-07-12 | 2008-05-21 | Werner Naser | Direkte bestimmung des quotients von analyt- zu referenzmolekülen |
| DE10040904A1 (de) | 2000-08-18 | 2002-02-28 | Boeger Rainer H | Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen |
| US7241856B2 (en) | 2003-06-02 | 2007-07-10 | Pentron Clinical Technologies Llc | Dental resins, dental composite materials, and method of manufacture thereof |
| JP4214271B2 (ja) | 2002-10-15 | 2009-01-28 | アークレイ株式会社 | クレアチニン測定用試験片 |
| US7501053B2 (en) | 2002-10-23 | 2009-03-10 | Abbott Laboratories | Biosensor having improved hematocrit and oxygen biases |
| AU2003290784A1 (en) | 2002-11-15 | 2004-06-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for detecting asymmetric dimethylarginine in a biological sample |
| US20050148029A1 (en) | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| EP1666884B1 (en) | 2004-11-04 | 2009-04-01 | GermedIQ Forschungs- und Entwicklungsgesellschaft mbH | Method for determination of arginine, methylated arginines and derivatives thereof |
| US8424012B1 (en) | 2004-11-15 | 2013-04-16 | Nvidia Corporation | Context switching on a video processor having a scalar execution unit and a vector execution unit |
| WO2006078813A2 (en) | 2005-01-21 | 2006-07-27 | Biosite Incorporated | Arginine analogs, and methods for their synthesis and use |
| JP2007176872A (ja) | 2005-12-28 | 2007-07-12 | Sentan Seimei Kagaku Kenkyusho:Kk | アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法 |
| FR2919063B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal. |
| JP5385914B2 (ja) * | 2007-12-05 | 2014-01-08 | キングス カレッジ ロンドン | 方法及び組成物 |
| PL2313364T3 (pl) * | 2008-08-07 | 2021-03-08 | Idexx Laboratories, Inc. | Sposoby wykrywania symetrycznej dimetyloargininy |
| CA2763948C (en) * | 2009-06-02 | 2019-03-12 | Biocrates Life Sciences Ag | Combination of amino acids, acylcarnitines and biogenic amines for the assessment of chronic kidney disease |
| CN101587118B (zh) * | 2009-07-03 | 2012-09-12 | 长春迪瑞医疗科技股份有限公司 | 肌酐尿液分析试纸及制备方法 |
| CN101598727B (zh) * | 2009-07-09 | 2012-10-10 | 上海科华生物工程股份有限公司 | 定量测定人体血液尿素含量的干化学试纸 |
| US9285246B2 (en) * | 2010-02-12 | 2016-03-15 | Intuitive Surgical Operations, Inc. | Method and system for absolute three-dimensional measurements using a twist-insensitive shape sensor |
| CN101865911A (zh) * | 2010-03-16 | 2010-10-20 | 苏州市玮琪生物科技有限公司 | 一种尿肌酐定量检测卡 |
| EP2612147B1 (de) | 2010-11-17 | 2016-03-30 | Karl-Heinz Kellner | Automatenfähiger immunoassay für biogene amine |
| JP2012112785A (ja) | 2010-11-24 | 2012-06-14 | Tohoku Univ | 透析膜の評価方法 |
| JP5925026B2 (ja) * | 2011-04-28 | 2016-05-25 | アークレイ株式会社 | クレアチニン測定用乾式試験片及びクレアチニン測定法 |
| AU2012271718A1 (en) * | 2011-06-16 | 2014-01-09 | Baylor Research Institute | Analysis of total homocysteine and methylmalonic acid in plasma by LC-MS/MS from a plasma separator device (PSD) |
| JP2013178239A (ja) * | 2012-01-31 | 2013-09-09 | Ajinomoto Co Inc | 早期腎症の評価方法、早期腎症評価装置、早期腎症評価方法、早期腎症評価プログラム、早期腎症評価システムおよび情報通信端末装置 |
| US20140038203A1 (en) * | 2012-07-09 | 2014-02-06 | Musc Foundation For Research Development | Methods for detecting or predicting kidney disease |
| HUE045723T2 (hu) | 2013-09-05 | 2020-01-28 | Idexx Lab Inc | Módszerek vesebetegség kimutatására |
-
2014
- 2014-09-05 HU HUE14842603A patent/HUE045723T2/hu unknown
- 2014-09-05 NZ NZ717554A patent/NZ717554A/en unknown
- 2014-09-05 KR KR1020217020124A patent/KR102412431B1/ko active Active
- 2014-09-05 ES ES14842603T patent/ES2746008T3/es active Active
- 2014-09-05 KR KR1020167009015A patent/KR102273028B1/ko active Active
- 2014-09-05 DK DK14842603.4T patent/DK3041576T3/da active
- 2014-09-05 HR HRP20191569 patent/HRP20191569T1/hr unknown
- 2014-09-05 EP EP23207400.5A patent/EP4295907A3/en active Pending
- 2014-09-05 RS RSP20191171 patent/RS59287B1/sr unknown
- 2014-09-05 WO PCT/US2014/054278 patent/WO2015035155A1/en not_active Ceased
- 2014-09-05 CA CA2923140A patent/CA2923140C/en active Active
- 2014-09-05 JP JP2016540417A patent/JP6657096B2/ja active Active
- 2014-09-05 AU AU2014315063A patent/AU2014315063B2/en active Active
- 2014-09-05 CA CA3213810A patent/CA3213810A1/en active Pending
- 2014-09-05 SI SI201431344T patent/SI3041576T1/sl unknown
- 2014-09-05 CN CN201480060296.4A patent/CN105705202B/zh active Active
- 2014-09-05 EP EP14842603.4A patent/EP3041576B1/en active Active
- 2014-09-05 ES ES18196516T patent/ES2969979T3/es active Active
- 2014-09-05 LT LT14842603T patent/LT3041576T/lt unknown
- 2014-09-05 MX MX2016002922A patent/MX383274B/es unknown
- 2014-09-05 PL PL14842603T patent/PL3041576T3/pl unknown
- 2014-09-05 SM SM20190526T patent/SMT201900526T1/it unknown
- 2014-09-05 PT PT14842603T patent/PT3041576T/pt unknown
- 2014-09-05 EP EP18196516.1A patent/EP3480600B1/en active Active
-
2016
- 2016-03-04 US US15/061,327 patent/US11035861B2/en active Active
- 2016-03-04 MX MX2021006716A patent/MX2021006716A/es unknown
-
2019
- 2019-09-12 CY CY20191100954T patent/CY1123179T1/el unknown
-
2020
- 2020-02-05 JP JP2020017580A patent/JP2020073927A/ja active Pending
- 2020-10-16 AU AU2020256440A patent/AU2020256440B2/en active Active
-
2021
- 2021-06-09 US US17/343,369 patent/US20220137059A1/en not_active Abandoned
-
2022
- 2022-02-02 JP JP2022014586A patent/JP2022070879A/ja active Pending
-
2023
- 2023-11-14 JP JP2023193309A patent/JP2024020376A/ja active Pending
-
2025
- 2025-05-06 US US19/199,936 patent/US20250271442A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285521A (en) | Assays for single molecule detection | |
| IL281485B (en) | Tracked all-terrain vehicle | |
| DK3041576T3 (da) | Fremgangsmåder til at detektere nyresygdom | |
| DK2972351T3 (da) | Forbedrede analysemetoder | |
| IL246002A0 (en) | Novel methods | |
| DK2996556T3 (da) | System til billedstyret procedure | |
| LT3074534T (lt) | Būdai, skirti polinukleotido sekoskaitai | |
| IL243311A0 (en) | Novel antibody frameworks | |
| DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
| DK3736291T5 (da) | Anti-FCRH5-antistoffer | |
| DK2881868T3 (da) | Søgegrænseflade | |
| EP3083682C0 (en) | DOUBLE SPECIFICITY ANTIBODIES | |
| LT3060041T (lt) | Prostaciklino junginiai | |
| DK3004155T3 (da) | Peptidforbindelse | |
| DK3708583T3 (da) | Ikke-fucosylerede anti-fgfr2iiib-antistoffer | |
| HRP20171851T1 (hr) | Spojevi tetrahidropirolotiazina | |
| DK2970389T3 (da) | Farmaceutiske forbindelser | |
| DK3076786T3 (da) | Fælde | |
| DK3041349T3 (da) | Anordning til angrebsdiagnose | |
| DK3068800T3 (da) | FcRn-specifikke antistoffer | |
| DK2969098T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
| DK2971191T3 (da) | Lactosegenvinding | |
| DK3065774T3 (da) | Anti-CCL17-antistoffer | |
| IL240904A0 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| GB201317621D0 (en) | Kidney disease biomarker |